Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-1981 | 06-1981 | 09-1980 | 06-1980 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 136 | N/A | 194 |
| Marketable Securities | N/A | 1,598 | N/A | 2,330 |
| Receivables | N/A | 983 | N/A | 712 |
| Other current assets | 0 | 221 | 0 | 112 |
| TOTAL | $N/A | $2,938 | $N/A | $3,347 |
| Non-Current Assets | ||||
| PPE Net | N/A | 248 | N/A | 222 |
| Investments And Advances | 0 | 8,453 | 0 | 7,262 |
| Other Non-Current Assets | 0 | 167 | 0 | 119 |
| TOTAL | $N/A | $8,868 | $N/A | $7,603 |
| Total Assets | $N/A | $11,665 | $N/A | $10,849 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 216 | 0 | 121 |
| Accrued Expenses | N/A | 918 | N/A | 444 |
| TOTAL | $N/A | $1,454 | $N/A | $1,832 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,454 | $N/A | $1,832 |
| Shareholders' Equity | ||||
| Common Shares | N/A | 6,988 | N/A | 6,183 |
| Retained earnings | N/A | 3,162 | N/A | 2,763 |
| Other shareholders' equity | 0 | 60 | 0 | 71 |
| TOTAL | $N/A | $10,210 | $N/A | $9,017 |
| Total Liabilities And Equity | $0 | $11,664 | $0 | $10,849 |